Status:
COMPLETED
Multi-parametric Breast Ultrasound Imaging as a Potential Biomarker for Breast Cancer
Lead Sponsor:
Swiss Federal Institute of Technology
Collaborating Sponsors:
Kantonsspital Baden
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
It is studied whether multi-parametric biomarkers such as speed-of-sound imaging or others, applied during breast ultrasound (BUS) imaging allows to classify lesions according to its malignancy. The s...
Detailed Description
Patients with a palpable lump in the breast or suspicious findings in X-ray mammography typically undergo breast ultrasound examination as a supplemental imaging modality. Findings are then used for t...
Eligibility Criteria
Inclusion
- Women who are suspected or suspected of having breast cancer and who are advised to perform a detailed breast ultrasound or tissue sampling (biopsy)
- Classification into groups:
- Group 1: Foreseen for BUS guided biopsy
- Group 2: BI-RADS classification I, II and III and foreseen for BUS only based diagnosis
Exclusion
- Lactating women
- Women with mastitis
- Vulnerable persons
Key Trial Info
Start Date :
November 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 13 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04480437
Start Date
November 15 2020
End Date
December 13 2021
Last Update
December 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kantonsspital Baden
Baden, Switzerland, 5404